Skip to main content

Bioneer Obtains CE-IVD Marking for HIV-1 Kit

NEW YORK (GenomeWeb) — South Korean molecular diagnostics firm Bioneer said today that it has received CE-IVD marking for its RT-PCR-based HIV-1 quantitative analysis kit.

The kit is designed to quantify HIV-1 RNA in blood samples and runs on Bioneer's ExiStation automated molecular diagnostics system. It is now available in the EU and countries recognizing the CE mark.

Bioneer said it is the first Asian company to receive CE-IVD marking for an HIV-1 quantitative analysis kit.

In 2016, Bioneer said its three-in-one test kit for Zika, dengue, and chikungunya viruses were deemed eligible for procurement by the World Health Organization.

The Scan

Gap in COVAX Doses

BBC News reports that COVAX is experiencing a vaccine shortfall, as the Serum Institute of India has paused exports.

Sanofi, GSK Report Promising Results

The Wall Street Journal reports that the candidate SARS-CoV-2 vaccine from Sanofi and GlaxoSmithKline has had encouraging early results.

Influence of Luck

The New York Times examines how the US avoided variant-fueled increases in COVID-19 cases.

PLOS Papers on Retina GWAS, Hantaan Virus, COVID-19 Phenome-Wide Association Study

In PLOS this week: genome-wide association study of retinal morphology, analysis of hantaan virus found in a mouse, and more.